Cargando…
Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study
Liver cirrhosis is a disease characterised by multiple complications and a poor prognosis. The prevalence is increasing worldwide. Chronic inflammation is ongoing in liver cirrhosis. No cure for the inflammation is available, and the current treatment of liver cirrhosis is only symptomatic. However,...
Autores principales: | Kronborg, Thit Mynster, Ytting, Henriette, Hobolth, Lise, Møller, Søren, Kimer, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495012/ https://www.ncbi.nlm.nih.gov/pubmed/34631742 http://dx.doi.org/10.3389/fmed.2021.718896 |
Ejemplares similares
-
The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial
por: Kimer, Nina, et al.
Publicado: (2022) -
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
por: Mynster Kronborg, Thit, et al.
Publicado: (2023) -
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
por: Kronborg, Thit M., et al.
Publicado: (2023) -
Suboptimal diagnostic accuracy of ultrasound and CT for compensated cirrhosis: Evidence from prospective cohort studies
por: Hetland, Liv E., et al.
Publicado: (2023) -
Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series
por: Kimer, Nina, et al.
Publicado: (2020)